Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: DSUVIA Early Evaluation of Pain Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating DSUVIA for acute pain in traumatic injury has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DSUVIA (SUFENTANIL)

Snippet

Sponsor: Frank Guyette | Conditions: Traumatic Injury | Phase 3 | Status: COMPLETED | Results posted: 2025-04-30